Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy

被引:0
作者
Holgersson, Georg [1 ,2 ]
Bergstrtom, Stefan [1 ,2 ]
Liv, Per [1 ]
Nilsson, Jonas [1 ,2 ]
Edlund, Per [2 ]
Blomberg, Carl [1 ,2 ]
Nyman, Jan [3 ]
Friesland, Signe [4 ]
Ekman, Simon [5 ]
Asklund, Thomas [6 ]
Henriksson, Roger [6 ]
Bergqvist, Michael [1 ,2 ,6 ]
机构
[1] Uppsala Univ, Gavle Hosp, Ctr Res & Dev, Gavle, Sweden
[2] Gavle Cent Hosp, Dept Oncol, SE-80187 Gavle, Sweden
[3] Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden
[4] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[5] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden
[6] Umea Univ Hosp, Dept Radiat Sci & Oncol, S-90185 Umea, Sweden
关键词
NSCLC; radiotherapy; toxicity; esophagitis; survival; RADIATION; CHEMOTHERAPY; CHEMORADIATION; CONCURRENT; THERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To elucidate the impact of different forms of radiation toxicities (esophagitis, radiation pneumonitis, mucositis and hoarseness), on the survival of patients treated with curatively intended radiotherapy for non-small cell lung cancer (NSCLC). Patients and Methods: Data were individually collected retrospectively for all patients diagnosed with NSCLC subjected to curatively intended radiotherapy (>= 50 Gy) in Sweden during the time period 1990 to 2000. Results: Esophagitis was the only radiation-induced toxicity with an impact on survival (hazard ratio=0.83, p=0.016). However, in a multivariate model, with clinical-and treatment-related factors taken into consideration, the impact of esophagitis on survival was no longer statistically significant (hazard ratio=0.88, p=0.17). Conclusion: The effect on survival seen in univariate analysis may be related to higher radiation dose and to the higher prevalence of chemotherapy in this group. The results do not suggest that the toxicities examined have any detrimental effect on overall survival.
引用
收藏
页码:5491 / 5497
页数:7
相关论文
共 14 条
[1]  
[Anonymous], STAT DAT
[2]  
[Anonymous], 2014, CLIN ADV HEMATOLOGY, V12, P2
[3]   Phase III study of the eastern cooperative oncology group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer [J].
Belani, CP ;
Wang, W ;
Johnson, DH ;
Wagner, H ;
Schiller, J ;
Veeder, M ;
Mehta, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3760-3767
[4]   Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy [J].
Belderbos, J ;
Heemsbergen, W ;
Hoogeman, M ;
Pengel, K ;
Rossi, M ;
Lebesque, J .
RADIOTHERAPY AND ONCOLOGY, 2005, 75 (02) :157-164
[5]   Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy [J].
Dang, Jun ;
Li, Guang ;
Zang, Shuang ;
Zhang, Shuo ;
Yao, Lei .
RADIATION ONCOLOGY, 2014, 9
[6]   Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients [J].
Dehing-Oberije, Cary ;
De Ruysscher, Dirk ;
Petit, Steven ;
Van Meerbeeck, Jan ;
Vandecasteele, Katrien ;
De Neve, Wilfried ;
Dingemans, Anne Marie C. ;
El Naqa, Issam ;
Deasy, Joseph ;
Bradley, Jeff ;
Huang, Ellen ;
Lambin, Philippe .
RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) :455-461
[7]   Chemoradiation for Definitive, Preoperative, or Postoperative Therapy of Locally Advanced Non-Small Cell Lung Cancer [J].
Feliciano, Josephine ;
Feigenberg, Steven ;
Mehta, Minesh .
CANCER JOURNAL, 2013, 19 (03) :222-230
[8]   The changing epidemiology of lung cancer in Europe [J].
Janssen-Heijnen, MLG ;
Coebergh, JWW .
LUNG CANCER, 2003, 41 (03) :245-258
[9]   High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results of a radiation dose escalation study [J].
Kong, FM ;
Ten Haken, RK ;
Schipper, MJ ;
Sullivan, MA ;
Chen, M ;
Lopez, C ;
Kalemkerian, GP ;
Hayman, JA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02) :324-333
[10]   RADIOTHERAPY ALONE VERSUS COMBINED CHEMOTHERAPY AND RADIOTHERAPY IN NONRESECTABLE NON-SMALL-CELL LUNG-CANCER - 1ST ANALYSIS OF A RANDOMIZED TRIAL IN 353 PATIENTS [J].
LECHEVALIER, T ;
ARRIAGADA, R ;
QUOIX, E ;
RUFFIE, P ;
MARTIN, M ;
TARAYRE, M ;
LACOMBETERRIER, MJ ;
DOUILLARD, JY ;
LAPLANCHE, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (06) :417-423